RESUMO
Data and results from interlaboratory comparison (ILC) studies, external quality assessment (EQA) and proficiency testing (PT) activities are important and valuable contributions both to the further development of all disciplines of medical laboratory diagnostics, and to the evaluation and comparison of in vitro diagnostic assays. So far, however, there are no recommendations as to which essential items should be addressed in publications on interlaboratory comparisons. The European Organization of External Quality Assurance Providers in Laboratory Medicine (EQALM) recognized the need for such recommendations, and these were developed by a group of experts. The result of this endeavor is the EQALM Statement on items recommended to be addressed in publications on interlaboratory comparison activities (PubILC), in conjunction with a user-friendly checklist. Once adopted by authors and journals, the EQALM Statement will ensure essential information and/or study-related facts are included within publications on EQA/PT activities.
RESUMO
Background Some clinical chemistry measurement methods are vulnerable to interference if hemolyzed serum samples are used. The aims of this study were: (1) to obtain updated information about how hemolysis affects clinical chemistry test results on different instrument platforms used in Nordic laboratories, and (2) to obtain data on how test results from hemolyzed samples are reported in Nordic laboratories. Methods Four identical samples containing different degrees of hemolysis were prepared and distributed to 145 laboratories in the Nordic countries. The laboratories were asked to measure the concentration of cell-free hemoglobin (Hb), together with 15 clinical chemistry analytes. In addition, the laboratories completed a questionnaire about how hemolyzed samples are handled and reported. Results Automated detection of hemolysis in all routine patient samples was used by 63% of laboratories, and 88% had written procedures on how to handle hemolyzed samples. The different instrument platforms measured comparable mean Hb concentrations in the four samples. For most analytes, hemolysis caused a homogenous degree of interference regardless of the instrument platform used, except for alkaline phosphatase (ALP), bilirubin (total) and creatine kinase (CK). The recommended cut-off points for rejection of a result varied substantially between the manufacturers. The laboratories differed in how they reported test results, even when they used the same type of instrument. Conclusions Most of the analytes were homogeneously affected by hemolysis, regardless of the instrument used. There is large variation, however, between the laboratories on how they report test results from hemolyzed samples, even when they use the same type of instrument.
Assuntos
Química Clínica/métodos , Testes Hematológicos/métodos , Hemólise/fisiologia , Humanos , Laboratórios , Doadores de TecidosRESUMO
Each year more than 70% (25 mill) of all electronic health documents between secondary and primary health sector in Denmark are exchanged electronically using European EDI standards. Despite this widely use there have been several problems in showing the transferred data in correct and full context. These problems are solved in the 3 years MedCom certification and consolidation project. The project financed by Ministry of Health, Danish County Association and others through MedCom, involved all relevant health professional groups, organisations, all SW suppliers and all local governments. A new detailed and exact documentation with recommendations and obligatory needs published in "The Good EDI letters" was made, followed by training courses for programmers, test and certification of IT systems by MedCom and finally implementation of certified systems by all users in the country. The certification and implementation process are followed on www.medcom.dk The results are now a high quality of information and the state of art: One and only way of exchanging documents which are accepted by health professionals and implemented by all SW companies at all users. To day only MedCom certified IT systems are used[2] and the certification is a must for SW companies to be in the market.